Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
0.0280
0.00 (0.00%)
At close: Oct 2, 2026
SGXC:9G2 Revenue
In the fiscal year ending June 30, 2026, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.72M SGD with 0.05% growth. Singapore Institute of Advanced Medicine Holdings had revenue of 3.65M in the quarter ending June 30, 2026, a decrease of -1.98%.
Revenue
15.72M
Revenue Growth
+0.05%
P/S Ratio
2.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 15.72M | 8.38K | 0.05% |
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vallianz Holdings | 252.46M |
| UG Healthcare Corporation | 150.82M |
| Lincotrade & Associates Holdings | 129.50M |
| Zixin Group Holdings | 113.51M |
| ISOTeam | 105.75M |
| Kim Heng | 97.73M |
| Wong Fong Industries | 79.06M |
| Mencast Holdings | 42.72M |